Skip to main content
Clinical Trials/DRKS00005970
DRKS00005970
Completed
N/A

Development, validation and clinical use of the dynamic pruritus score (DPS) - PruDPS

niversitätsklinikum Münster0 sites157 target enrollmentApril 15, 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitätsklinikum Münster
Enrollment
157
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 15, 2014
End Date
October 11, 2013
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsklinikum Münster

Eligibility Criteria

Inclusion Criteria

  • Age \>18, male and female, out\- and in\-patients with atopic dermatitis, urticaria, prurigo nodularis and chronic pruritus.
  • The patients received a topical therapy (between V1 and V2\) during the study for 2 weeks.

Exclusion Criteria

  • Age below 18 years, pregnancy, breastfeeding, active psychosomatic and psychiatric disorders, known active malignant underlying diseases, previous studies within the last 4 weeks, drug use, drug abuse, topical application of tacrolimus, pimecrolimus, polidocanol, menthol, cannabinoid agonists or capsaicin within the last 2 weeks prior to the study, systemic administration of steroids, cyclosporine A and other immunosuppressive agents, naltrexone, UV therapy within the last two weeks before the study start, systemic administration of antihistamines, topical steroids within one week prior to the study, acute exacerbation or cutaneous infections in atopic dermatitis

Outcomes

Primary Outcomes

Not specified

Similar Trials